Riociguat for the Treatment of Patients with Pulmonary Arterial Hypertension (PAH)- Responder Analysis of Who Functional Class III Patients from the Patent-1 Study
Nov 1, 2013, 00:00
10.1016/j.jval.2013.08.1206
https://www.valueinhealthjournal.com/article/S1098-3015(13)03111-2/fulltext
Title :
Riociguat for the Treatment of Patients with Pulmonary Arterial Hypertension (PAH)- Responder Analysis of Who Functional Class III Patients from the Patent-1 Study
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)03111-2&doi=10.1016/j.jval.2013.08.1206
First page :
A513
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1060